Sanchez, Kate B.

HRN: 29-19-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/28/2026
08/04/2026
IV
500mg
Q8hrs
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: